Long-term Survival in a Patient with Recurrent Pulmonary Metastases from Uterine Leiomyosarcoma.

about

Long-term Survival in a Patient with Recurrent Pulmonary Metastases from Uterine Leiomyosarcoma.

Item

http://www.wikidata.org/entity/Q36493924

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Long-term Survival in a Patien ...... s from Uterine Leiomyosarcoma.

@ast

Long-term Survival in a Patien ...... s from Uterine Leiomyosarcoma.

@en

type

Item

label

Long-term Survival in a Patien ...... s from Uterine Leiomyosarcoma.

@ast

Long-term Survival in a Patien ...... s from Uterine Leiomyosarcoma.

@en

prefLabel

Long-term Survival in a Patien ...... s from Uterine Leiomyosarcoma.

@ast

Long-term Survival in a Patien ...... s from Uterine Leiomyosarcoma.

@en

P1476

Long-term Survival in a Patien ...... s from Uterine Leiomyosarcoma.

@en

P2093

Gwenalyn Garcia

http://www.w3.org/2001/XMLSchema#string

Meekoo Dhar

http://www.w3.org/2001/XMLSchema#string

Shiksha Kedia

http://www.w3.org/2001/XMLSchema#string

P2860

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.

Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors.

Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.

Recent developments in uterine mesenchymal neoplasms.

Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma.

Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases.

Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.

Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival.

Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma G

P304

e405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7759/CUREUS.405

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287147009

http://www.w3.org/2001/XMLSchema#string

P698

26819867

http://www.w3.org/2001/XMLSchema#string

P932

4724211

http://www.w3.org/2001/XMLSchema#string